<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01455298</url>
  </required_header>
  <id_info>
    <org_study_id>2011.664</org_study_id>
    <nct_id>NCT01455298</nct_id>
  </id_info>
  <brief_title>Liver Disease in Adults With Alpha-1 AT Deficiency</brief_title>
  <acronym>LIDIA-A1AT</acronym>
  <official_title>Research of Infra Clinical Liver Injuries in Adult Patients Presented With Alpha-1 AT Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This cohort study will evaluate the prevalence of the infra clinical liver injuries among a
      group of adult patients presenting with Alpha-1 AT deficiency followed up in a large
      university hospital in Lyon, France.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The prevalence of infra clinical liver injuries</measure>
    <time_frame>At least one day depending on the schedule of the exams</time_frame>
    <description>The prevalence of infra clinical liver injuries (lesions or liver abnormalities) in a cohort of adult patients presenting an Alpha-1 AT deficiency. Suspicion of fibrosis was defined as liver stiffness &gt; 7.2kPa measured by transient elastography (TE).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>morphological liver complications description</measure>
    <time_frame>At least one day depending on the schedule of the exams</time_frame>
    <description>To describe all the morphological liver complications present at the moment of the investigation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>measure of biological parameters</measure>
    <time_frame>At least one day depending on the schedule of the exams</time_frame>
    <description>- To measure the biological parameters (as AST, ALT, GGT, total bilirubin, lymphocytes, platelets, FibroTest score) and radiological aspects (TE score, liver aspect evaluated by ultrasound)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Alpha-1 AT Deficiency</condition>
  <arm_group>
    <arm_group_label>Transient elastography and fibrotest</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transient Elastography and fibrotest</intervention_name>
    <description>a Transient Elastography and an ultrasound are performed.</description>
    <arm_group_label>Transient elastography and fibrotest</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18 years old

          -  Presenting an Alpha-1 AT deficiency (Alpha-1 AT level &lt;0.8g/l at the time of
             diagnosis)

        Exclusion Criteria:

          -  Patients presenting a liver disease not related to the Alpha-1 AT deficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-François MORNEX, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Femme Mère Enfant - Hospices Civils de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2011</study_first_submitted>
  <study_first_submitted_qc>October 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2011</study_first_posted>
  <last_update_submitted>October 30, 2012</last_update_submitted>
  <last_update_submitted_qc>October 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alpha-1 AT deficiency</keyword>
  <keyword>liver injury</keyword>
  <keyword>Transient Elastography</keyword>
  <keyword>FibroTest</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alpha 1-Antitrypsin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

